Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spasms, Infantile | 9 | 2013 | 298 | 1.470 |
Why?
|
| Anticonvulsants | 8 | 2013 | 1906 | 0.730 |
Why?
|
| Vasa Previa | 1 | 2020 | 37 | 0.660 |
Why?
|
| Umbilical Cord | 1 | 2020 | 177 | 0.630 |
Why?
|
| Epilepsies, Partial | 5 | 2011 | 431 | 0.540 |
Why?
|
| Seizures | 7 | 2012 | 2957 | 0.450 |
Why?
|
| Vigabatrin | 2 | 2012 | 88 | 0.420 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2020 | 1755 | 0.390 |
Why?
|
| Spasm | 1 | 2011 | 130 | 0.380 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2011 | 74 | 0.380 |
Why?
|
| Epilepsy, Benign Neonatal | 1 | 2010 | 13 | 0.350 |
Why?
|
| KCNQ2 Potassium Channel | 1 | 2010 | 19 | 0.350 |
Why?
|
| Angelman Syndrome | 1 | 2012 | 140 | 0.350 |
Why?
|
| GTP Cyclohydrolase | 1 | 2008 | 47 | 0.300 |
Why?
|
| Isoxazoles | 1 | 2010 | 232 | 0.300 |
Why?
|
| Tuberous Sclerosis | 2 | 2012 | 1030 | 0.280 |
Why?
|
| Electroencephalography | 6 | 2012 | 6237 | 0.240 |
Why?
|
| Reaction Time | 1 | 2011 | 2089 | 0.240 |
Why?
|
| Epilepsy | 4 | 2013 | 3290 | 0.230 |
Why?
|
| Dystonic Disorders | 1 | 2008 | 350 | 0.220 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2011 | 2518 | 0.200 |
Why?
|
| Neurosurgical Procedures | 1 | 2010 | 2072 | 0.170 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2020 | 583 | 0.140 |
Why?
|
| Republic of Korea | 4 | 2011 | 590 | 0.130 |
Why?
|
| Stress, Psychological | 1 | 2011 | 4481 | 0.130 |
Why?
|
| Animals, Newborn | 4 | 2012 | 2677 | 0.110 |
Why?
|
| Age of Onset | 2 | 2012 | 3306 | 0.110 |
Why?
|
| Betamethasone | 2 | 2011 | 49 | 0.110 |
Why?
|
| Infant | 11 | 2013 | 36192 | 0.110 |
Why?
|
| N-Methylaspartate | 2 | 2011 | 231 | 0.110 |
Why?
|
| snRNP Core Proteins | 1 | 2012 | 22 | 0.100 |
Why?
|
| Infant, Newborn | 6 | 2012 | 26198 | 0.100 |
Why?
|
| Disease Models, Animal | 4 | 2012 | 18253 | 0.100 |
Why?
|
| Menkes Kinky Hair Syndrome | 1 | 2011 | 19 | 0.100 |
Why?
|
| Neuropeptide Y | 1 | 2012 | 192 | 0.100 |
Why?
|
| Pilocarpine | 1 | 2011 | 64 | 0.100 |
Why?
|
| Ketone Bodies | 1 | 2011 | 76 | 0.100 |
Why?
|
| Convulsants | 1 | 2011 | 70 | 0.090 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2010 | 46 | 0.090 |
Why?
|
| Mice, Inbred ICR | 1 | 2011 | 364 | 0.090 |
Why?
|
| Epilepsy, Rolandic | 1 | 2011 | 54 | 0.090 |
Why?
|
| Cation Transport Proteins | 1 | 2011 | 327 | 0.080 |
Why?
|
| Korea | 1 | 2008 | 98 | 0.080 |
Why?
|
| Isoleucine | 1 | 2008 | 110 | 0.080 |
Why?
|
| Child, Preschool | 7 | 2013 | 42230 | 0.080 |
Why?
|
| Mutation | 3 | 2011 | 30054 | 0.070 |
Why?
|
| Threonine | 1 | 2008 | 271 | 0.070 |
Why?
|
| Epilepsy, Generalized | 1 | 2009 | 178 | 0.070 |
Why?
|
| Psychosurgery | 1 | 2007 | 86 | 0.070 |
Why?
|
| Female | 16 | 2020 | 392686 | 0.070 |
Why?
|
| Adenosine Triphosphatases | 1 | 2011 | 836 | 0.070 |
Why?
|
| Benzodiazepines | 1 | 2013 | 1132 | 0.070 |
Why?
|
| Male | 18 | 2013 | 360842 | 0.070 |
Why?
|
| Child | 9 | 2013 | 80156 | 0.070 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2012 | 2510 | 0.070 |
Why?
|
| Astrocytoma | 1 | 2010 | 775 | 0.070 |
Why?
|
| Pregnancy | 3 | 2020 | 29876 | 0.060 |
Why?
|
| Intelligence | 1 | 2011 | 924 | 0.060 |
Why?
|
| Methylphenidate | 1 | 2009 | 488 | 0.060 |
Why?
|
| Sirolimus | 1 | 2012 | 1533 | 0.060 |
Why?
|
| Vagus Nerve | 1 | 2007 | 458 | 0.060 |
Why?
|
| Drug Resistance | 1 | 2010 | 1596 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 12975 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2012 | 8181 | 0.060 |
Why?
|
| Rats | 4 | 2012 | 23741 | 0.050 |
Why?
|
| Drug Therapy, Combination | 2 | 2010 | 6312 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2012 | 1899 | 0.050 |
Why?
|
| Corpus Callosum | 1 | 2007 | 751 | 0.050 |
Why?
|
| Humans | 19 | 2020 | 761572 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 2 | 2011 | 4740 | 0.050 |
Why?
|
| Pedigree | 1 | 2010 | 4542 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 4853 | 0.050 |
Why?
|
| Electric Stimulation Therapy | 1 | 2007 | 628 | 0.050 |
Why?
|
| Central Nervous System Stimulants | 1 | 2009 | 1177 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2010 | 10766 | 0.050 |
Why?
|
| Treatment Outcome | 6 | 2013 | 64684 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 4111 | 0.040 |
Why?
|
| Hypnotics and Sedatives | 1 | 2007 | 1179 | 0.040 |
Why?
|
| Migraine Disorders | 1 | 2011 | 1703 | 0.040 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2011 | 618 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 2226 | 0.040 |
Why?
|
| Brain Ischemia | 1 | 2011 | 3049 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2013 | 80646 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2007 | 2630 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2011 | 36429 | 0.030 |
Why?
|
| Critical Care | 1 | 2007 | 2697 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 11904 | 0.030 |
Why?
|
| Critical Illness | 1 | 2007 | 2723 | 0.030 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2009 | 3708 | 0.030 |
Why?
|
| Animals | 5 | 2012 | 168467 | 0.030 |
Why?
|
| Adolescent | 5 | 2013 | 88324 | 0.030 |
Why?
|
| GABA Agents | 1 | 2011 | 41 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2010 | 39107 | 0.020 |
Why?
|
| Exploratory Behavior | 1 | 2011 | 279 | 0.020 |
Why?
|
| Methylprednisolone | 1 | 2011 | 385 | 0.020 |
Why?
|
| Intelligence Tests | 1 | 2011 | 503 | 0.020 |
Why?
|
| Maze Learning | 1 | 2011 | 483 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2010 | 9031 | 0.020 |
Why?
|
| Stroke | 1 | 2011 | 9758 | 0.020 |
Why?
|
| Moyamoya Disease | 1 | 2011 | 265 | 0.020 |
Why?
|
| Quality of Life | 1 | 2009 | 13367 | 0.020 |
Why?
|
| Movement Disorders | 1 | 2011 | 459 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2009 | 962 | 0.020 |
Why?
|
| Midazolam | 1 | 2007 | 266 | 0.020 |
Why?
|
| Adult | 1 | 2020 | 221203 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 3416 | 0.020 |
Why?
|
| Age Factors | 2 | 2012 | 18398 | 0.020 |
Why?
|
| Hypothalamus | 1 | 2010 | 999 | 0.020 |
Why?
|
| Brain Stem | 1 | 2010 | 858 | 0.020 |
Why?
|
| Time Factors | 3 | 2013 | 39970 | 0.010 |
Why?
|
| Anesthetics, Intravenous | 1 | 2007 | 395 | 0.010 |
Why?
|
| Fentanyl | 1 | 2007 | 434 | 0.010 |
Why?
|
| Mice | 1 | 2011 | 81533 | 0.010 |
Why?
|
| Brain | 1 | 2010 | 27120 | 0.010 |
Why?
|
| Vascular Diseases | 1 | 2011 | 1161 | 0.010 |
Why?
|
| Conscious Sedation | 1 | 2007 | 532 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2007 | 2218 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2011 | 2161 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2009 | 4021 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 6484 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2011 | 7054 | 0.010 |
Why?
|
| Hippocampus | 1 | 2010 | 3766 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2009 | 8633 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2011 | 5779 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2007 | 8528 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 14607 | 0.010 |
Why?
|
| Comorbidity | 1 | 2009 | 10508 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 2007 | 3744 | 0.010 |
Why?
|
| Length of Stay | 1 | 2007 | 6426 | 0.010 |
Why?
|
| Cognition | 1 | 2011 | 6992 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 59255 | 0.000 |
Why?
|
| Risk Factors | 1 | 2011 | 74213 | 0.000 |
Why?
|
Concepts
(132)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_